Article Figures & Tables
Figures
- Fig. 1.
Sensitivity of WT and MtDNA mutator (POLGexo−) MEFs to mitochondrial toxins. Mitochondrial mutator MEFs were more sensitive than WT MEFs to inhibition of colony formation by azide (P=0.025), ethidium bromide (P=0.046), FCCP (P=0.002) and chloramphenicol (P<0.001). A very strong trend for a difference in sensitivity was also found for rotenone (P=0.053). Colony counting assays were performed to determine IC50 values for (A) azide, (B) ethidium bromide (EtBr), (C) tert-butyl hydroperoxide, (D) rotenone, (E) antimycin A, (F) hydrogen peroxide (H2O2), (G) FCCP, (H) oligomycin, and (I) chloramphenicol. Experiments were performed with three independently derived E1A immortalized WT and mtDNA mutator clone lines (n=3). Bars represent mean±s.e.m. Unpaired t-tests were performed with * indicating a P-value of <0.05 and ** indicating a P-value <0.001.
- Fig. 2.
O2 consumption rates of WT and POLGexo− MEFs treated with AICAR or rapamycin. (A) O2 consumption rates after 24 h in HGM. (B) O2 consumption rates after 48 h in HGM. (C) O2 consumption rates after 24 h in LGPM. (D) O2 consumption rates after 30 h in LGPM. (E) O2 consumption rates after 10 days in HGPUM. (F) O2 consumption rates after 20 days in HGPUM. Rapamycin transiently increases oxygen consumption in WT MEFs at the 24 h time point either in the absence or presence of pyruvate. Respiratory deficits in POLGexo− MEFs were revealed by the LGPM used in panels C and D and the HGPUM used in panels E and F. Experiments were repeated twice using three technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher's LSD post hoc analysis was performed. *P<0.05, **P<0.001.
- Fig. 3.
Effects of AICAR or rapamycin on ROS production of WT and POLGexo− MEFs under low glucose conditions. Rapamycin treatment in LGM or LGPM had no effect on ROS production. 0.5% ethanol (EtOH) was added as a positive control to induce ROS production. (A) ROS levels after 24 h in LGM. (B) ROS levels after 48 h in LGM. (C) ROS levels after 24 h in LGPM. (D) ROS levels after 48 h in LGPM. Experiments were repeated twice using five technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher's LSD post hoc analysis was performed. *P<0.05, **P<0.001.
- Fig. 4.
Effects of AICAR or rapamycin on ROS production of WT and POLGexo− MEFs under high glucose conditions. 0.5% ethanol (EtOH) was added as a positive control to induce ROS production. (A) ROS levels after 24 h in HGM. (B) ROS levels after 48 h in HGM. (C) ROS levels after 24 h in HGPM. (D) ROS levels after 48 h in HGPM. (E) ROS levels after 10 days in HGPUM. (F) ROS levels after 20 days in HGPUM. Experiments were repeated twice using five technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher's LSD post hoc analysis was performed. *P<0.05, **P<0.001.
- Fig. 5.
Effects of AICAR or rapamycin on ATP levels of WT and POLGexo− MEFs under low glucose conditions. (A) ATP levels after 24 h in LGM. (B) ATP levels after 48 h in LGM. (C) ATP levels after 24 h in LGPM. (D) ATP levels after 48 h in LGPM. Experiments were repeated twice using five technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher's LSD post hoc analysis was performed. *P<0.05, **P<0.001.
- Fig. 6.
Effects of AICAR or rapamycin on ATP levels of WT and POLGexo− MEFs under high glucose conditions. (A) ATP levels after 24 h in HGM. (B) ATP levels after 48 h in HGM. (C) ATP levels after 24 h in HGPM. (D) ATP levels after 48 h in HGPM. (E) ATP levels after 10 days in HGPUM. (F) ATP levels after 20 days in HGPUM. Experiments were repeated twice using five technical replicates each time. Bars represent mean±s.e.m. Two-way ANOVA with Fisher's LSD post hoc analysis was performed. **P<0.001.
Article Navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Biology Open and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Interview - Sonu Baral
First author Sonu shares the story behind her latest BiO research, what this means for the field and where her science journey is heading to next.
How to promote your research
Publishing your paper is just the start of communicating your research to the world. Some researchers feel uneasy about self-promotion, but chances are your existing network is interested in what you’re doing – you just need to tell them! Sharing your work is useful and professional. Follow our 10 tips to get started.